10q10k10q10k.net
Medpace Holdings, Inc.

Medpace Holdings, Inc.MEDPEarnings & Financial Report

Nasdaq

Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.

MEDP Q4 2025 Key Financial Metrics

Revenue

$708.5M

Gross Profit

N/A

Operating Profit

$153.3M

Net Profit

$135.1M

Gross Margin

N/A

Operating Margin

21.6%

Net Margin

19.1%

YoY Growth

32.0%

EPS

$4.65

Financial Flow

Medpace Holdings, Inc. Q4 2025 Financial Summary

Medpace Holdings, Inc. reported revenue of $708.5M for Q4 2025, with a net profit of $135.1M (19.1% margin). Cost of goods sold was N/A, operating expenses totaled N/A.

Key Financial Metrics

Total Revenue$708.5M
Net Profit$135.1M
Gross MarginN/A
Operating Margin21.6%
Report PeriodQ4 2025

Medpace Holdings, Inc. Annual Revenue by Year

Medpace Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.5B).

YearAnnual Revenue
2025$2.5B
2024$2.1B
2023$1.9B
2022$1.5B

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$511.0M$528.1M$533.3M$536.6M$558.6M$603.3M$659.9M$708.5M
YoY Growth17.7%14.6%8.3%7.7%9.3%14.2%23.7%32.0%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$1.80B$1.92B$2.08B$2.10B$1.90B$1.57B$1.75B$1.98B
Liabilities$1.12B$1.16B$1.20B$1.28B$1.30B$1.40B$1.46B$1.52B
Equity$671.5M$763.6M$881.4M$825.5M$593.6M$172.4M$293.6M$459.1M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$152.7M$116.4M$149.1M$190.7M$125.8M$148.5M$246.2M$192.7M